Imlygic (Talimogene): What to Expect

This page is for people offered Imlygic (talimogene laherparepvec) for melanoma and those close to them. It covers how it works, what it is approved for, how it is given, keeping others safe, and when to get help.

Talimogene laherparepvec is a living, weakened herpes simplex type 1 virus — the virus behind cold sores — changed in a laboratory.

The label says it was changed by removing some genes and adding others. One added human gene makes GM-CSF, a signal that calls immune cells in.

It is designed to multiply inside cancer cells and burst them, and to help trigger an immune response. Imlygic is the brand name.

The FDA label carries a limitation of use: talimogene laherparepvec has not been shown to improve overall survival, and it has not been shown to affect melanoma that has spread to internal organs.

The approved job is local. It treats melanoma lesions in and just under the skin, and in lymph nodes, that surgery cannot remove and that have come back after an earlier operation. It is not a whole-body treatment, and it is not a substitute for one.

Because it is a live virus, two groups are ruled out entirely.

People whose immune system is suppressed cannot have it. That includes people with an inherited or acquired immune deficiency, leukemia, lymphoma, HIV, or anyone taking medicines that weaken the immune system. In them, the virus can spread through the body, and that has been fatal.

People who are pregnant cannot have it either.

Tell your team about steroids, transplant medicines and any immune-suppressing drug you take, even a short course.

There is no drip and no tablet. A clinician injects the liquid straight into melanoma lesions in the skin or lymph nodes, using a fine needle and sometimes ultrasound for deeper ones.

The first visit uses a lower strength. Three weeks later comes a stronger dose, and after that visits are roughly every two weeks. The number of lesions injected and the volume depend on their size.

The product is stored in a deep freezer, at around minus 90 to minus 70 degrees Celsius, and thawed just before use. That is why appointments are not easy to move at short notice.

The virus can pass to other people through contact with an injection site or its dressings.

• Keep the treated areas covered with an airtight, watertight dressing for at least the first week after each visit, or longer if the site is weeping.
• If a dressing comes loose, replace it. Wear gloves, then wash your hands.
• Do not touch or scratch the injection sites.
• Put used dressings and gloves in a sealed bag before throwing them away.
• Keep close contacts who are pregnant, newborn, or immune-suppressed away from the sites and dressings.

Staff who are pregnant or immune-suppressed do not prepare or give this treatment for the same reason.

If you or a close contact develops a cold sore, an ulcer, or an eye infection, contact your team. It may be an ordinary herpes infection. The label notes that this virus is sensitive to acyclovir, so antiviral treatment can also blunt how well the therapy works. That trade-off is your team's call, not one to make at a pharmacy counter.

The most common effects on the label are tiredness, chills, fever, nausea, flu-like illness, and injection-site pain. The label says they can happen any time during treatment but were more frequent in the first 3 months. Most went away within 72 hours.

The label lists other problems too. Tumor tissue at an injection site can break down or form an ulcer. Skin infection (cellulitis) and infection spreading through the body have been reported, and some sites heal slowly. Lesions near a major airway need care, because airway blockage has been reported.

• Call 911 or go to an emergency department if your breathing becomes noisy or blocked, especially when a treated lesion sits near your windpipe or throat. Do not drive yourself.
• Call 911 or go to an emergency department if a fever comes with shaking chills and you feel suddenly and badly unwell, or you are dizzy, confused, or breathing fast. Those together can mean an infection spreading into the blood, which will not wait for a clinic slot. Do not drive yourself.
• Call your care team the same day if an injection site turns hot, spreads red beyond its edge, weeps pus, or your temperature reaches 100.4°F (38°C) or higher. Ring the same day as well for a painful red eye or light hurting your eyes, in you or in a close contact.
• Call your care team within a day or two if a treated site will not close over, a dressing keeps lifting off a weeping lesion, or someone in your household develops a cold sore or an unexplained ulcer.

• https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=64ffb680-ea8c-42fc-9649-9e8c0eb77ddb
• https://www.cancer.gov/about-cancer/treatment/drugs/talimogenelaherparepvec